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"I wish I had a twin, so I could know what I'd look like without plastic
surgery."
-JOAN RIVERs1
Jessica Lee2 was unhappy with her appearance and underwent
breast augmentation surgery to obtain a shapelier figure. She was
overjoyed with her new look until the ill-fated day that her body
started to reject one of the implants. Much to her dismay, the saline-
filled insert started to protrude and eventually broke through the skin.
Jessica had to have revision surgery to fix the problem3 caused by a
capsular contracture, a difficulty that occurs when tight scar tissue
forms around an implant.4
INTRODUCTION
Breast augmentation is one of the most popular cosmetic proce-
dures in the United States.5 The surgery is performed by the uses of
different substances, such as saline or fat to enlarge breast size, to
reestablish breast dimension or to reconstruct the chest area after a
mastectomy or injury. Common difficulties include capsular contrac-
ture, additional surgery, implant removal, rupture or deflation of the
implant and bleeding. Occasionally, patients are not pleased with the
aesthetics of the implants, claiming that they are improperly posi-
tioned, asymmetrical, too large or too small, fake in appearance, or
their scars are too wide or thick.
Cosmetic surgery has become more accessible to a wider portion
of society6 resulting in 15.9 million operations and minimally-invasive
procedures being performed in the United States in 2015.7 This is a
1. Joan Rivers, BBC NEWS (Sept. 5, 2015), http://www.bbc.com/news/entertainment-
arts-29075239.
2. This is a fictitious name.
3. This story is based upon: Anna Hodgekiss, Boob Job Horror for Woman, DAILY
MAIL (May 18, 2016), http://www.dailymail.co.uk/health/article-2295139/Boob-job-horror-
woman-25-implant-fell-OUT-chest-leaving-lopsided-seven-months.html.
4. Id. As noted in Toole v. McClintock, 999 F.2d 1430 (11th Cir. 1993) capsular
contracture is "a condition in which a capsule of scar tissue forms around the implant and
gradually contracts, deforming or hardening the breast."
5. Portions of this article have been reprinted with permission. Samuel D. Hodge Jr.,
et al., When Breast Augmentation Surgery Goes Awry: Litigation and Liability Issues, PENN.
B. AsS'N Q., Jan. 2017, at 21-30.
6. THm INCREASE IN POPULARITY OF COSMETIC SURGERY OVER THE LAST DECADE, 22
FACIAL PLASTIc SURGERY TODAY (Facial Plastic Surgery, Alexandria, Va.), 4 Q 2008, http://
www.aafprs.org/patient/fps-today/vol22/04/pg1.html.




115 percent increase in the number of procedures since the turn of the
21st century.8 This surge is the result of a multitude of factors such as
the number of healthcare professionals performing the techniques, the
influence of the media, and the less-invasive nature of the surgeries.9
It is also a reflection of our fascination with celebrities, the numerous
stories about their appearance enhancing surgeries, and the informa-
tion available through the Internet about the different procedures.10
Cosmetic procedures offer immediate satisfaction but they are
not without risk.1 Complications range from an infection at the inci-
sion site to permanent nerve damage and even death. 12 For example, it
has been projected that those who undergo breast augmentation sur-
gery experience more than a 25% chance of developing complications
that mandate an additional procedure.13 The Food and Drug Adminis-
tration has even published a booklet that highlights the most common
problems encountered with silicone gel-filled and saline-filled breast
implants.14
This article will provide a medical/legal perspective to breast
augmentation surgery. Written by an attorney who teaches anatomy
and a plastic surgeon who routinely performs the procedure, it will ini-
tially offer a medical analysis of how the procedure is performed along
with its attendant risks. The second part will focus on the court cases
and legal theories that have arisen when things go wrong. The article
will explain the convoluted litigation history involving breast augmen-
tation when suits were common place and a group of experts linked
breast implants to the development of autoimmune disease without
any real scientific basis to support their opinions. It will conclude with
a discussion of the various legal theories currently being asserted when
the surgery does not live up to the patient's expectations.
8. Annual Plastic Surgery Statistics, supra note 7.
9. See Adrian Furnham & James Levitas, Factors that Motivate People to Undergo
Cosmetic Surgery, 20 CAN. J. PIAST. SURGERY Winter 2012, at 47-50, https://www.ncbi.nlm
.nih.gov/pmc/articles/PMC3513261/ (last visited July 12, 2017).
10. THE INCREASE IN POPUIARITY OF COSMETIC SURGERY OVER THE LAST DECADE, supra
note 6.
11. Statistics on Complications of Cosmetic Surgery, MODERN MOM, http://www.modern
mom.com/2e31d432-051f-11e2-9d62-404062497d7e.htnl (last visited June 27, 2017).
12. Id.
13. Id.
14. Breast Implants: Local Complications and Adverse Outcomes, U.S. FOOD & DRUG
ADMIN., http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/Implantsand
Prosthetics/BreastImplants/ucm259296.htm (last visited June 27, 2017).
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I. BREAST AUGMENTATION - AN OVERVIEW
As noted in Calvin v. Allure Medical Spa, "breast augmenta-
tion goes to the essence of what plastic surgeons do."1 5 This procedure
uses various materials, such as saline or fat to enlarge the breasts, to
reestablish breast size as the result of weight loss or childbirth or to
restructure the chest area after a mastectomy or injury.1 6 The Ameri-
can Society of Plastic Surgeons further notes that augmentation
mammoplasty is a highly personal decision that serves several pur-
poses: it can enhance fullness and projection of the breasts, it can
improve a person's body image, and it can boast an individual's
shape.17 It will not, however, correct breasts that severely sag. That
requires a breast lift."
Historically, Japanese prostitutes were the first to enlarge their
breast during World War II to attract American military personnel.
Paraffin, sponges and non-medical grade silicone were used to achieve
this purpose. The idea of breast enlargements really gained traction as
the result of the busty appearance of Marilyn Monroe and Jane Rus-
sell, who emphasized their curvy shapes, and started women thinking
about increasing their breasts size.19
Silicone implants were developed by two physicians in Texas,
and in 1962, Timmie Jean Lindsey became the first person to receive
these enhancements.20 Breast augmentation surgery is now the sec-
ond-most popular cosmetic procedure worldwide, after liposuction.21 In
addition to those who want to improve their shape, the cosmetic proce-
dure has found another very valuable use; to help those who have
undergone mastectomies to regain their self-esteem.22 On the other
hand, about 43,000 implants were removed in 2015 for a variety of rea-
sons demonstrating that the surgery is not always a panacea or a
permanent solution.23
15. Calvin v. Allure Medical Spa, 2012 WL 8009769, at *5 (Mich. Cir. Ct. July 16,
2012).
16. What Is Breast Augmentation?, Am. Soc'Y OF PLASTIc SURGEONS, https://www.plas-
ticsurgery.org/cosmetic-procedures/breast-augmentation (last visited June 27, 2017).
17. Id.
18. Id.
19. Claire Bowes & Cordelia Hebblethwaite, A Brief History of Breast Enlargements,
BBC NEws (Mar. 29, 2012), http://www.bbc.com/news/magazine-17511491.
20. Chronology of Silicone Breast Implants, PBS, http://www.pbs.org/wgbh/pages/
frontline/implants/cron.html (last visited July 12, 2017).
21. Bowes & Hebblethwaite, supra note 19.
22. Id.
23. Diana Zuckerman, et al., Facts About Breast Implants, OUR BODIES OURSELVES
(Oct. 25, 2016), http://www.ourbodiesourselves.org/health-info/facts-about-breast-implants/.
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A. Anatomy of the Breast
Breasts are not uniform in size, weight or shape but they have
the same anatomic construction. These tear-shaped glands cover the
chest muscles and are suspended over the ribs. In turn, they are kept
in position by supporting soft tissues which give breasts their shape.24
Anatomically, the female breast is composed of an array of fat cells
known as adipose tissue.25 The mammary glands have no muscle and
the volume of fat establishes their size.26 The milk producing part of
the breast will have 10 to 20 sections positioned in a circular pattern
dubbed "lobes."27 Each lobe consists of a number of smaller lobules, the
glandular tissue that creates milk in nursing women.28 Milk ducts con-
nect the lobes and lobules and serve as conduits to transport the milk
to the nipple.29 The darker aspect of the breast encircling the nipple
is the areola or focal point of the gland.3 0 They come in a variety of
sizes and colors and include tiny sweat glands called Montgomery's
glands which secrete the liquid that lubricates the nipple
during breastfeeding.31
The breast also contains a series of blood and lymph vessels as
well as lymph nodes.32 These lymphatic vessels, which resemble tubes,
drain to the lymph nodes located in the underarm and underneath the
sternum.3 3 The breast obtains its blood supply principally from the in-
ternal mammary artery. This blood vessel is located below the core
breast tissue and delivers oxygen and other nutrients to the gland.34
24. Robert Valdes, How Breast Implants Work, How STuFF WORKS, http://sci-
ence.howstuffworks.com/innovationeveryday-innovations/breast-implantl.htm (last visited
July 12, 2017).
25. Breast Anatomy, NAT'L BREAST CANCER FOUND., http://www.nationalbreastcancer
.org/breast-anatomy (last visited June 7, 2016).
26. Picture of the Breasts, WEBMD, http://www.webmd.com/women/picture-of-the-
breasts (last visited July 12, 2017).
27. Breast Anatomy, supra note 25.
28. Id.
29. Id.
30. Picture of the Breasts, supra note 26.
31. Melissa Stoppler, Breast Anatomy, MEDICINENET.COM, http://www.medicinenet
.com/breastanatomy/article.htm (last visited July 12, 2017).
32. Picture of the Breasts, supra note 26; Lymph Node Status, SUSAN G. KOMEN, http://
ww5.komen.org/BreastCancer/LymphNodeStatus.html (last visited July 12, 2017) (defining
lymph nodes as "small clumps of immune cells that act as filters for the lymphatic system").
33. Id.
34. Anat6my and Physiology of the Breast, JOHNS HoPKINS MED., http://pathology.jhu
.edu/breast/anatomy.php (last visited November 18, 2016).
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B. Kinds of Implants
This cosmetic procedure increases or reestablishes breast size
by using silicone and saline implants or fat transfer.3 5 Saline im-
plants36 are encased in a silicone shell filled with sterile salt water.37
The casing is empty when first introduced into the breast and then
filled with liquid to achieve the preferred size.38 A silicone implant, on
the other hand, contains an outer shell that is prefilled with a plastic
gel.3 9 Women tend to favor this category of implant40 because it feels
more like a natural breast but it presents a greater hazard of leaking.41
One might be surprised that silicone implants are still being
used in view of action by the FDA in 1992 prohibiting their sale and
the flurry of litigation that erupted over their use.4 2 After conducting
more research on the issue, however, the FDA determined in 2006 to
again allow certain silicone breast implants to be utilized in breast
augmentations.4 3
35. Breast Augmentation, SMART BEAUTY GuIDE, http://www.smartbeautyguide.com/
procedures/breast/breast-augmentation (last visited July 12, 2017).
36. Saline implants have several advantages such as they have a detailed history of
safe use, the saline is similar to body fluids as it can be reabsorbed into the surrounding
tissue if it ruptures and they come in round or anatomical shapes. See Breast Enlargement
(Implants), NHS CHOICES, http://www.nhs.uk/Conditions/Breast-implants/Pages/Considera-
tions.aspx (last visited July 12, 2017).
37. Breast Implants, WEBMD, http://www.webmd.com/beauty/breast-implants/cosme
tic-procedures-breast-augmentation (last visited July 12, 2017).
38. Breast Implants: Saline vs. Silicone, MAYO CLINIC (June 13, 2015), http://www
.mayoclinic.org/healthy-lifestyle/womens-health/in-depth/breast-implants/art-20045957.
39. Id.
40. The benefits of silicone gel implants are that have a prolonged history of safe use,
they may be less probable to crinkle than the others forms of implants, they are manufac-
tured in contour shapes known as a teardrop, and the gel can be soft and pliable like the
tissues of the breast. The major problem with the silicone implant is a rupture of the shell
causing the gel to spread into the breast causing small lumps to develop called siliconomas.
See Breast Enlargement (Implants), supra note 36.
41. Breast Implants: Saline vs. Silicone, supra note 38; Breast Implants, supra note 37.
42. For a chronology of the history of breast implants and related litigation, see Chro-
nology of Silicone Breast Implants, supra note 20.
43. Stephanie Saul, F.D.A. Will Allow Breast Implants Made of Silicone, N. Y. Times
(Nov. 18, 2006), http://www.nytimes.com/2006/11/18/washington/18breast.html. The female
breast continues to develop into a woman's late teens or early twenties. Therefore, the FDA
mandates that a female be at least 18 years old before she may receive a saline implant.
Silicone implants, however, require that the patient have reached her twenty-second birth-




Breast enhancement, breast augmentation, augmentation
mammoplasty, or breast implant surgery is routinely performed by a
plastic surgeon and there are a number of methods to perform the op-
eration. The aim is to make an incision in an inconspicuous area to
minimize visible scarring.44 Incision placement will vary depending
upon the type of implant, the amount of the enlargement, the patient's
anatomy and the preference of the patient and physician. Typical inci-
sion areas include the region around the nipple, under the fold of the
breast, in the arm pit or the belly button.45 The place of the incision,
however, can have an impact on the prominence of the scar and post-
surgical complications.4 6
The underside of the breast is the most popular location be-
cause the incision can be made in the natural folds of the skin. This
placement, however, may cause a more visible scar, particularly in
younger and thin women.4 7 An under the arm incision, a technique
known as an transaxillary incision, will usually involve the use of an
endoscope to assist the surgeon guide the implant into its proper loca-
tion. 8 Its obvious advantage is that there will be no visible scar around
the breast.49 The disadvantages are that of a higher complication rate
of malposition, poor symmetry, increased bleeding, and the inability to
use silicone implants. A periareolar incision involves cutting around
the edge of the nipple but its drawback is that the patient may experi-
ence a loss or change of feeling in the areola.50
Employing the undersurface of the breast as the incision point
will mandate a 4 to 5 cm opening to insert the implant into a generous
pocket beneath (submuscular) or above (subglandular) the pectoralis
muscle.5 1 The submuscular approach allows direct and easy access to
the muscle in order to dissect a pocket beneath it, and it provides a
44. Breast Augmentation - Augmentation Mammoplasty, AM. Soc'Y OF PIASTIC SUR-
GEONs, https://www.plasticsurgery.org/cosmetic-procedures/breast-augmentation/procedure
(last visited July 12, 2017).
45. Id.; Breast Implant Surgery, U.S. FOOD AND DRUG ADMIN., http://www.fda.gov/
MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/Breastlmplants/
ucm064176.htm (last visited July 12, 2017) (The FDA-approved labeling discourages ur-
geons from placing the breast implant through the belly-button).




50. Breast Augmentation - Augmentation Mammoplasty, supra note 44.
51. Id.
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predictable and reliable result with the lowest complication rate. Addi-
tionally, the implant is less likely to become exposed, or "rejected", so
to speak, due to the strong muscle overlying it.
There are variations to this technique. For instance, the sur-
geon may utilize a saline implant, because it can be rolled up like a
cigarette and inserted through an even smaller incision and then filled
once in place under the muscle, or some surgeons will use a subglandu-
lar approach and place the implant on top of the pectoralis
muscle.5 2 The disadvantages of the subglandular technique include
slightly increased pain when elevating the muscle, as well as increased
anatomical deformity, which is basically the movement of the implant
with activation of the overlying pectoralis muscle.
D. Complications
Traditional complications involving breast augmentation in-
clude; capsular contracture, nipple numbness, additional surgery,
implant removal, and leakage, rupture, or deflation of the implant.53
Patients routinely ask, "What if my body rejects the implant?".54 In
reality, it is not a case of rejection. The implant, whether saline or a
silicone gel, still possesses a silicone shell or outer layer.55 That layer is
a foreign body, and if one develops even a small infection after the sur-
gery, bacteria can adhere tightly to the implant making it difficult to
resolve the infection. As the infection builds, it may erode through the
incision and begin to drain fluid or pus. It is through this opening that
the implant will extrude. A significant infection is difficult to destroy
without removal of the implant much like an infected artificial knee or
heart valve.
Bleeding is a rare occurrence, but it can be encountered. Blood
can accumulate and form a hematoma. This complication can some-
52. Dr. Miles, the co-author of this piece, prefers going under the muscle, as it is yet
one additional layer of well perfused and strong muscle protecting the implant from the
outside world. It helps conceal rippling or waviness of the implant that can be seen when it
sits just under the skin. It also provides an "internal massage" to the tissue around the
implant every time the muscle fires and that helps reduce capsular contracture rates.
53. Breast Implant Complications Booklet, U.S. FOOD AND DRUG ADMIN., http://www
.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/Breastm-
plants/ucm259296.htm (last visited June 6, 2016).
54. Samuel D. Hodge, et al., Everything you wanted to know about breast augmentation
surgery but were afraid to ask: A medical - legal overview (forthcoming 2017).
55. See Silicone Vs. Saline Breast Implants - What Are The Differences, CT. FOR AES-
THETIC SURGERY, http://www.epsteinplasticsurgery.com/blog/breast-augmentation/silicone-




times lead to additional surgery to locate the source of the bleeding and
to evacuate the hematoma. If the patient's body makes an inappropri-
ately thick scar that becomes tight and starts to squeeze the breast, a
distortion of the implant and pain can occur. This complication is
known as a high grade capsular contracture and sometimes demands
additional surgery to resect the tight scar tissue.
Sometimes, patients are unhappy with the look of the implants,
maintaining that they are malpositioned, asymmetrical, too large, too
small, fake in appearance, or their scars are too wide or thick. Women
can also suffer injury to the sensory nerve to the areolar complex. This
complication occurs in about fifteen percent of cases5 6 and is significant
in that sensual arousal of the nipple will be lost, as will the suckling
response of a nursing infant, thus creating an inability to breastfeed.
An extremely rare complication is a pneumothorax or collapsed lung.
This can happen when dissecting the plane beneath the pectoralis
muscle just above the ribs. If the patient is very thin, so too are the
tissues in that area and one can inadvertently cause a small hole or
tear in the pleura, causing a collapsed lung.
Hypertrophic scarring occurs in two to five percent of pa-
tients.5 7 As noted in New York v. Coote, hypertrophic scarring is a
bulky red scar that occurs after surgery and "almost looks piled up
with scar tissue."5 8 Proper treatment may require additional surgery
or steroid injections into the scar area.5 9
II. A RETROSPECTIVE REVIEW OF BREAST IMPLANT LITIGATION
Breast implant litigation enjoys a robust, but controversial his-
tory. The first successful lawsuit over ruptured breast implants
occurred in 1977, when a Cleveland woman obtained a $170,000 settle-
ment from Dow Corning.60 Three years later, Ralph Nader issued a
warning that silicone breast implants caused cancer6 l and the race to
the courthouse was set in motion. A few years later, a woman was
awarded $211,000 in compensatory and $1.5 million in punitive dam-
56. Hodge, supra note 54.
57. The risk of complications from breast augmentation surgery, OBP MED., https://
obpmedical.com/resource-center/blog/the-risk-of-complications-from-breast-augmentation-
surgery/ (last visited June 7, 2016).
58. People v. Coote, 110 A.D.3d 485, 485 (S. Ct. N.Y. 2013).
59. The risk of complications from breast augmentation surgery, supra note 57.
60. Chronology of Silicone Breast Implants, supra note 20.
61. Id.
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ages after a jury determined that the plaintiffs systemic autoimmune
disease was caused by her silicone breast implants.62
Breast implant litigation received a lot of attention in 1991
when a jury awarded a woman $840,000 in compensatory damages and
$6.5 million in punitive damages.63 The facts show that in 1976, Mari-
ann Hopkins had a mastectomy and implants made by Dow Corning
were used to reconstruct her breasts. Subsequently, she was diagnosed
with a mixed connective tissue disease. Continued ifficulties with her
implants required additional surgery which revealed that her implants
had ruptured.64 The implants were sent to Dow for analysis who deter-
mined that upon "examination and testing of both envelopes [it] found
no evidence to indicate that any of the damage was manufacturer re-
lated."65 Two years later, the plaintiffs mother learned that there
might be a link between the ruptured implants and her daughter's im-
mune disorder.
The plaintiff sued Dow claiming fraud, strict products liability,
and breach of warranties. Plaintiffs counsel presented evidence that
the defendant rushed the development of the implants, failed to prop-
erly test them, and disregarded knowledge of unfavorable health
outcomes associated with the units.66 The evidence also revealed that
the implants had a high rate of rupture and Dow was aware of the toxic
effects of silicone on the body.67
The media's coverage over silicone breast implants exploded in
1991 as the result of a lawsuit filed by Pamela Johnson.68 The plaintiff
asserted that silicone leaked from her implants thereby compromising
her immune system. This resulted in her having a partial mastectomy.
A jury awarded Ms. Johnson $25 million which was the largest award
against a breast implant manufacturer up to that time.6 9
This verdict was criticized in the American Medical Associa-
tion's Journal of Ethics which pointed out that the plaintiff was a
smoker with no known autoimmune disease. Instead, she had a mix of
62. Chronology of Silicone Breast Implants, supra note 20.
63. Hopkins v. Dow Corning Corp., 33 F.3d 1116 (9th Cir. 1994).
64. Id. at 1121.
65. Id. at 1119.
66. Hopkins, 33 F.3d at 1124.
67. Id.
68. See Kristin E. Schleiter, Silicone Breast Implant Litigation, AMA J. OF ETmcs: 12
VIRTUAL MENTOR (5), 389-94, http://journalofethics.ama-assn.org/2010/05/hlawl-1005.html
(last visited July 4, 2017).





non-specific complaints including chronic fatigue, muscle pain, joint
pain, headaches, and dizziness. It was claimed that the plaintiffs law-
yer generated great sympathy for his client by hiring a public relations
firm that obtained interviews with a variety of television shows includ-
ing 60 Minutes.70 The large verdict fueled an explosion of lawsuits.7 1
Contemporaneously, the FDA ordered manufacturers of silicone
gel breast implants to provide additional studies noting that the ex-
isting research was insufficient to prove the safety of the devices.72 In
1992, the agency determined that the sale of implants should be lim-
ited to women who have had mastectomies, breast deformities, or to
replace a broken gel implant.73 This ruling was greeted with mixed re-
sults. Some found the determination a much needed prophylactic
measure, while others condemned the FDA's order and the decision-
making process that produced it.7 Critics claimed that the FDA only
focused on the issue after the court cases surrounding implants had
increased and the news had focused on the issue.75 In other words, the
critics maintained that the ruling was "swayed by politics and other
extra-scientific concerns instead of being directed by science."76
In any event, the consequence of the negative pronouncement
by the FDA was immediate and devastating. Despite the agency's reas-
surances that people who had implants were in no danger, the damage
was done. The public felt that the FDA would not have taken such a
dramatic step unless there was a substantial risk. This resulted in a
70. See Schleiter, supra note 68.
71. Henry J. Reske, Record Implant Verdict, ABA J., Apr. 1993, at 24.
72. The FDA & Breast Implants, BREAST IMPLANT INFO, http://www.breastimplantinfo
.org/what-you-need-to-know/aathe-fda-breast-implants/ (last visited July 4, 2017).
73. Id.
74. See Shelly Friedland, FDA's Role in the Silicone Breast Implant Story, HARv. (Jan.
24, 1997), https://dash.harvard.edu/bitstream/handle/1/8846748/sfriedla.html?sequence=2.
75. Dr. Jack Fisher, a plastic surgeon, who has authored a book on the saga of breast
implants believes that problem and controversy over silicone gel breast implants occurred
during the late 1980's and 1990's as the result of a single person, David Kessler, head of the
FDA at the time. The author notes that Kessler "relied on dubious legal testimony to cast
doubt on the implants' safety while ignoring the ubiquity of silicone polymers in our envi-
ronment and their successful application in hundreds of medical devices over the previous
five decades." Monique Kenney, The Sad Saga ofSilicone Breast Implants, SCOOP.IT, https:/
/www.scoop.it/t/health-and-beauty-by-monique-kinney/p/4038621558/2015/03/07/the-sad-
saga-of-silicone-breast-implants (last visited Nov. 14, 2017) (citing Henry Miller, The Sad
Saga of Silicone Breast Implants, FORBES, (Mar. 4, 2015 6:00 A.M.), https://www.forbes.com/
sites/henrymiller/2015/03/04/infuriating-titbits-about-silicone-breast-implants/#
7d2 7 6 f02 1
4110
76. Id. (other criticisms focused based on the opinion and the fact that it was corrupted
by both improper information and the prejudice or lack of credentials of panel members).
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stream of women who returned to their surgeons demanding that their
implants be removed.77
These developments, and the growing financial toll, caused sev-
eral manufacturers to withdraw from the silicone breast implant
business.78 Breast implant companies continued to suffer setbacks
when, in 1994, a jury awarded three plaintiffs $27.9 million in compen-
satory and punitive damages based upon allegations of atypical lupus,
neurological impairment, or a "silicone induced" autoimmune
problem.79
Increasingly, women with breast implants stepped forward as-
serting a multitude of issues, and a small group of experts continued to
link breast implants to the development of autoimmune disease with-
out any real scientific basis to support their conclusions.8 0 Needing to
limit their financial losses, the breast-implant manufacturers con-
sented to a very large class-action settlement.8 1 A fund of $4.25 billion
was created for women with breast implants.8 2 This sum was split with
$1.2 billion being devoted to women asserting current implant-related
issues and the balance would be set aside for those with implants who
became sick over the next three decades.83
The wheels came off the wagon in the plaintiffs' successful run
of breast implant litigation in 1994 as the result of a study conducted
by the Mayo Clinic.8 4 The 30-year study published in the New England
Journal of Medicine found no connection between breast implants, con-
nective-tissue diseases, and other disorders.5 The article further noted
the earlier studies examining the link between silicone-containing
breast implants and connective-tissue disorders were methodologically
flawed with a lack of objective validation of the results.86 The Ameri-
can College of Rheumatology weighed in on the issue one year later.8 7
This organization noted there was no persuasive proof that silicone im-
77. Marcia Angell, Evaluating the Health Risks of Breast Implants: The Interplay of
Medical Science, the Law, and Public Opinion, 334 NEW. ENG. J. MED. 1513, 1514 (1996).
78. Chronology of Silicone Breast Implants, supra note 20.
79. Id.




84. See Sherine E. Gabriel et al., Risk of Connective-Tissue Diseases and Other Disor-
ders after Breast Implantation, 330 New. Eng. J. Med. 1697 (1994).
85. Id.
86. Id.




plants subjected women to any additional threat for- connective tissue
or rheumatic disease.88 They went on to say that anecdotal evidence
should no longer be utilized in an attempt to create such an association
in the courts or by the FDA.89 A variety of other organizations and
studies found no association between breast implants and the in-
creased risk for disease.90 The Food and Drug Administration reversed
its positon after a 14-year ban on the use of silence gel implants when,
in 2006, it approved implants by two manufactures for breast recon-
struction and augmentation.9 1
The public again became comfortable with breast augmentation
surgery and the raging controversy over the safety of implants seems
to be a thing of the past in most circles.92 Breast enhancement surgery
remains one of the most common cosmetic procedures with more than
350,000 operations being performed annually in the United States.93
III. CURRENT LITIGATION
Dockets are replete with thousands of lawsuits involving breast
implants. The volume of cases, however, is much less than 40 years ago
during the frenzy over the safety of the devices. Nevertheless, breast
augmentation is still a surgical procedure with its attendant complica-
tions and unfulfilled expectations by some patients. The types of
lawsuits and theories of liability run the gamut from cases of malprac-
tice to whether an exotic dancer can claim breast augmentation
surgery as a proper business expense. Interestingly, the cases involv-
ing breast implant litigation are not limited to the United States.94 A
number of courts from around the world have heard cases involving
breast implants. This summary, however, will focus on the lawsuits
88. Statement on Silicone Breast Implants, supra note 87.
89. Id.
90. A chronological listing of studies which found no link between disease and breast
implants can be found at David Bernstein, The Breast Implant Fiasco, 87 CALF. L. REV.
457, 457- 510 (1999).
91. Saul, supra note 43.
92. There is still a small number of people who believe that breast implants are dan-
gerous. See Nalini Chilkov, 25 Reasons Not o Get Breast Implants, HuFF PosT (Feb. 1,
2011), http://www.huffingtonpost.com/nalini-chilkov/breast-implant-surgery-_b_81
6 0 7 7
.html.
93. Jennifer Whitlock, Most Popular Plastic Surgeries, VERYWELL (Apr. 1, 2015), https:/
/www.verywell.com/most-popular-plastic-surgeries-3157239.
94. Women May Have to Pay Back Dodgy Breast Implant Damages, CBS NEWS (July 2,
2015), http://www.cbsnews.com/news/french-court-rules-no-compensation-over-faulty-pip-
french-breast-implants/ (illustrating how a French court ruled that a product testing firm
did not have to pay more than 3,000 women who had developed "leak-prone breast
implants").
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involving breast implants filed in the 21st Century. The history of liti-
gation before that time is covered in the previous section.
A. Capsular Contracture
Capsular contracture occurs when scar tissue forms around the
implant and "gradually contracts, deforming or hardening the
breast."95 This is an acknowledged risk of this form of cosmetic surgery
and it is estimated that around 10% of women with breast implants
will develop this painful condition.9 6 Statistically, there is a higher
rate of capsular contracture in those who obtain silicone implants as
compared to those with saline implants.9 7 Because the condition re-
sults from bacteria, it is a common source of breast implant litigation.
In Maynard v. Sena, the plaintiff filed a malpractice action
against a plastic surgeon claiming that he was negligent in her postop-
erative care by not wearing surgical gloves when he drained fluid that
had developed in the plaintiffs left breast as the result of a capsular
contracture.98 She maintained that this failure caused her to develop
an infection, which resulted in lengthy and extensive difficulties.99 A
defense verdict was rendered and the primary issue on appeal was
whether the trial judge committed error by allowing the physician to
testify as to his custom of always wearing gloves in his office when
conducting surgical procedures.10 0 Particularly persuasive in the
Court's choice to affirm the judgment was the trial court's statement
that: "Evidence of a habit of a person or the retained practice of an
organization is admissible to prove that the conduct of the person or
organization on a particular occasion was in conformity of the habit or
routine practice."101
Murphy v. U.S. also involved a non-sterile environment.102
Murphy had breast augmentation surgery at a military facility and
95. Toole v. McClintock, 999 F.2d 1430, 1431 (11th Cir. 1993).
96. Breast Implants Placement and Likelihood of Capsular Contracture, REALSELF
Q&A BLOG, https://www.realself.com/question/subfascial-subpectoral-breast-implant-capsu-
lar-contracture (last visited July 22, 2017).
97. Yasser El-Sheikh et al., Incidence of Capsular Contracture in Silicone versus Saline
Cosmetic Augmentation Mammoplasty: A Meta-Analysis, 16 n. 4 Can. J. Plastic. Surgery
211, 211 (2008), http://www.ncbi.nlm.nih.gov/pmdarticles/PMC2691025/.
98. Maynard v. Sena, 125 A.3d 541, 544 (Conn. App. Ct. 2015).
99. Id.
100. Id.
101. Maynard, 125 A.3d at 546.




soon discovered a lump in her breast, which caused increasing pain.103
A consultation with another surgeon revealed a four-inch human hair
was attached to the left implant which caused a capsular contrac-
ture.1 0 4 This condition was described as "a shrinkage of the natural
scar tissue that forms around a breast implant and causes the implant
to become tight and feel firm and hard."1 0 5 The primary dispute was
whether the strand of hair caused the capsular contracture.106 The
plaintiffs expert testified that capsular contracture develops in five
percent of breast implant patients.107 While the problem is not fully
understood, it is caused by something other than an implant that is left
inside the pocket of the breast such as bacterial or a human hair.10 8
The government's expert opined that if the hair found on the implant
had caused the capsular contracture, it would have resulted in an in-
flammatory response and the hair would have been surrounded by a
scar.109 Since the hair was attached to the implant rather than embed-
ded in a scar, the expert noted that the foreign matter did not cause the
condition.110 The court found in favor of the plaintiff and determined
that the hair was the primary cause or significantly exacerbated her
condition.1 1 The experts both agreed that bacteria is the primary cul-
prit in the development of this painful condition, but the court found
the explanation provided by claimant's expert more persuasive.112
B. Tax Deduction for Breast Implants
One of the more unusual cases involves a claim brought by
Cynthia Hess, a/k/a Chesty Love, challenging an Internal Revenue de-
termination that breast implants were not an ordinary and necessary
expense in relation to a business.113 Ms. Hess was a topless dancer
whose agent convinced her to have breast implants in order to enlarge
103. Murphy, 2009 WL 454627, at *1.




108. Murphy, 2009 WL 454627 at *2.
109. Id. at *3.
110. Id.
111. Id.
112. Murphy, 2009 WL 454627 at *3.
113. Julian Block, Tax Court Upholds Business-Expense Deduction for Topless Dancer's
Breast Implants, HUFFPOST (May 9, 2014), http://www.huffingtonpost.com/julian-block/
tax-court-upholds-busines b_5292707.html.
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her breast size from a 55FF to a 56 N.11 4 The Special Trial Judge deter-
mined that the surgical procedure was deducible because it enhanced
her breasts, was only useful in her line of work, and as such, the
breasts were a necessary business prop.1 1 5 The judge made the analogy
that the implants were similar to business cloths and uniforms.16 As
the court noted, "Because petitioner's implants were so extraordinarily
large, we find that they were useful only in her business.""7
C. Invasion of Privacy
An entity can be held liable for the disclosure of private infor-
mation about an individual, even if accurate, under the tort of the
public disclosure of a private fact." 8 This action is defined by the Re-
statement (Second) of Torts as the dissemination of private
information that "(a) would be highly offensive to a reasonable per-
son and (b) is not of legitimate concern to the public.""19 Would a
woman have a viable cause of action for invasion of privacy if her
plastic surgeon accidently sent pictures of her naked torso to the
human resources department of the plaintiffs employer for a pre-sur-
gery coverage determination, instead of to her insurance company?120
That is the issue in Mays v. The Marshall University Board of Gover-
nors.121 The plaintiff had a mastectomy and reconstructive surgery to
her left breast that involved the use of an implant.122 A few years later,
she became concerned over the appearance of her breast and visited a
surgeon about additional surgery.123 During the examination, pictures
were taken of her naked breast in order to obtain pre-approval for pay-
ment from her insurance carrier.124 Unfortunately, the pictures were
inadvertently sent to the plaintiffs employer.12 5 The transmittal letter
114. Hess v. Comm'r of Internal Revenue, 1994 U.S. Tax Ct. LEXIS 88, at *2-3 (May 4,
1994).
115. Id. at *11.
116. Id. at *10.
117. Id.
118. See Phyllis Karasov et al., Chapter 13: Privacy, in BUSINESS DISPUTES: CLAIMS AND
REMEDIES 13-1 (Edward T. Wahl ed., 2d ed. 2017), http/www.larkinhoffman.com/files/
OTHER/KarasovPrivacyMNCLE.pdf.
119. RESTATEMENT (SECOND) OF TORTS § 652D cmt. a (AM. LAW INST. 1977).
120. Mays v. Marshall Univ. Bd. of Governors, No. 14-0788, 2015 WL 6181508 (W. Va.
Oct. 20, 2015).
121. Id.
122. Id. at *1.
123. Id.




contained the plaintiffs name along with the images.126 1 The envelope
was opened by a representative of the Human Resource Department
who immediately showed them to her supervisor.127 The manager di-
rected that the pictures be forwarded to the plaintiff in a sealed
envelope marked confidential.1 2 8 The court dismissed the lawsuit not-
ing Mays' medical information was not disclosed to the public.129 It
ruled that tort entails widespread disclosure and it cannot be limited to
a small group of people.130 In this case, the pictures were only viewed
by two people so the plaintiff did not have a viable cause of action.13 1
Hetter v. Eight Judicial District Court In and For the County of
Clark, involved an invasion of privacy claim by a patient after her
plastic surgeon used her before and after breast augmentation pictures
in a brochure.132 The defendant countered that Hetter had consented
to the publication of the pictures in exchange for a reduction in the
price of the operation.133 During discovery, the trial judge issued an
order directing the doctor to disclose a list of his patients so that coun-
sel for the plaintiff could send a letter asking if the patients had viewed
the brochure.134 The defense filed a Writ of Mandamus challenging
this order on the basis of physician-patient privilege and relevancy.135
The court granted the request and prohibited the disclosure of the in-
formation.13 6 While disclosing a patient's identity does not always
violate the doctor-patient privilege, the revealing of a patient's name in
this situation discloses that plastic surgery is implicated.13 7 Most peo-
ple would consider "breast augmentation as a confidential matter they
would not want disclosed."138
126. Mays, 2015 WL 6181508.
127. Id.
128. Mays, 2015 WL 6181508 at *1.
129. Id.
130. Id. at *6-7
131. Id. at *7
132. Hetter v. Eight Judicial Dis. Court of State In & For Cty. of Clark, 874 P.2d 762
(Nev. 1994).
133. Id. at 763.
134. Id.
135. Hetter, 874 P.2d at 763.
136. Id. at 766.
137. Id. at 764.
138. Id. at 763.
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D. Defamation
A physician filed a defamation action against his patient over
negative comments that she posted on a website in Loftus v. Nazari.139
The facts demonstrate that Nazari had breast implant surgery and a
breast lift. 140 She was unhappy with the results and posted her opinion
on a website complaining that the doctor had left her with permanent
nerve damage, terrible scars and disfigured breasts.14 1 The defendant
then went on to say that she had filed a complaint with the U.S. Attor-
ney and the Ohio Medical Board.142 The court dismissed the claim
finding that the statements concerning her poor surgical results were
protected opinion.143
In Smith v. Garber, the plaintiff had a breast augmentation per-
formed by Dr. Garber.144 Because the plaintiff believed the surgery
was done incorrectly, she sued for malpractice.145 Subsequently, a
magazine ran a story about the notable career of Sal Calabro, M.D., a
well-known plastic surgeon, who was affiliated with Dr. Garber.146 The
article stated in part:
Over the years, Calabro has been named in a handful of lawsuits;
some were thrown out of court, and his name was removed from
others directed at the work of his associate physicians. Dr. Brett
Garber, who handles some of Calabro's breast work now, is involved
in two suits from patients at Calabro's center 'I'm pissed that I got
sued at Sal's, but do I think these are frivolous charges? Yes', he
says. 'Was Sal involved in either of them? No. When you're a celeb-
rity, you're going to get kooks.'147
This article prompted a second lawsuit for defamation in which
the claim was dismissed.14 8 The court stated that "questionable rheto-
ric or hyperbole do not constitute defamation."149 It was reasonable
139. Loftus v. Nazari, 21 F. Supp. 3d 849 (E. D. Ky. 2014).
140. Id. at 852.
141. Id.
142. Loftus, 21 F. Supp. At 852.
143. Id. at 856.
144. Smith v. Garber, No. CIV.A. 03-1424, 2003 WL 21960720, at *1 (E.D. Pa. June 25,
2003).
145. Id. at *1.
146. Id.
147. Smith, 2003 WL 21960720 at *1.
148. Id.
149. Id. at * 1.
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that the plaintiff would take offense to being referred to as a "kook",
but the article was not reasonably capable of a being defamatory.150
E. Social Security Disability
In Hays v. Colvin, the plaintiff applied for social security bene-
fits alleging a variety of ailments, one of which was related to her
breast implants.151 The standard for disability is "the inability to en-
gage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment which can be expected to
result in death or which has lasted or can be expected to last for a
continuous period of not less than 12 months."152 Determination of dis-
ability under the Social Security Act requires a five-step analysis:
(1) [the claimant] is unable to engage in substantial gainful activ-
ity; (2) has a severe medically determinable physical or mental
impairment; (3) has such an impairment that meets or equals a
Listing and meets the duration requirements; (4) can perform [her]
past relevant work, in light of his residual functional capacity; and
(5) can make an adjustment to other work, in light of [her] residual
functional capacity, age, education, and work experience.153
The plaintiff previously had silicone breast implants, which
were found to be leaking.154 These were eventually replaced with sa-
line implants.155 The plaintiff had trouble sitting, standing, lifting,
bending, and had several epidural blocks.156 Ultimately, the Adminis-
trative Law Judge ("AM") found that the plaintiff did not qualify for
disability benefits because she could still perform a full range of light
work, and her impairments could reasonably be expected to produce no
worse than a moderate degree of pain.157 The District Court upheld the
findings of the ALJ, because absent an abuse of discretion, the District
Court will not disturb the AL's findings.158
150. Id. at *2; see also, Fowler v. Capital Cities/ABC, Inc., No. CIV.A.3:00-CV-2417-P,
2002 WL 31230802 (N.D. Tex. 2002); Martinez v. Soignier, 570 So.2d 23 (La. Ct. App.1990).
151. Hays v. Colvin, No. 2:15-CV-00100-JEO, 2016 WL 1270524, at *1 (N.D. Ala. 2016).
152. Id. at *2; 42 U.S.C. § 423(d)(1)(A)(2015); 42 U.S.C. § 416(i)(1)(2004).
153. Hays, 2016 WL 1270524 at *2 (quoting Evans v. Comm'r, Soc. Sec. Admin., 551 F.
App'x 521, 524 (11th Cir. 2014)).
154. Id. at *4.
155. Id.
156. Hays, 2016 WL 1270524 at *4
157. Id. at *3.
158. Id. at *6.
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F. Preclusion of Expert Testimony
Novel scientific evidence is subject to challenge before the court
will allow the testimony.159 The admissibility of expert testimony in
federal and some state courts is governed by four factors set forth in
Daubert v. Merrell Dow Pharmaceuticals, Inc.1 6 0 The factors are: (1)
whether a theory or technique can be (and has been) tested; (2)
whether the theory or technique has been subjected to peer review and
publication; (3) the known or potential rate of error in using a particu-
lar scientific technique and the existence and maintenance of
standards controlling the technique's operation; and (4) whether the
theory or technique has been generally accepted in the particular sci-
entific field.161 While these factors are most commonly used, they are
neither definitive nor exhaustive.162
The Court in In re Dow Corning Corp. applied these factors in
relation to three expert witnesses for the plaintiff, who elected not to
participate in a settlement process as part of a confirmed Chapter 11
plan, and instead brought suit to recover for alleged injuries involving
silicone breast implants.163
The Court disqualified the first expert, Dr. Jerry Bush, because
he did not establish his knowledge or training as it relates to autoim-
mune disease.164 While Dr. Bush had knowledge, skill, experience, and
education as to internal medicine, he had no specific knowledge as to
whether silicone breast implants could cause autoimmune diseases.165
In his report, Dr. Bush never identified how the silicone implants
caused the plaintiffs autoimmune disease.166 He did not cite to any
theory that had been subject to peer review and publication, choosing
instead to merely summarize the plaintiffs medical history.16 7 Because
of these reasons, the Court found Dr. Bush's testimony would not as-
sist the jury in determining causation, and the Court precluded his
testimony. 168
159. See generally Daubert v. Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993).
160. Id. at 593-94.
161. Id.
162. Id.
163. In re Dow Corning Corp., 541 B.R. 643, 649-53 (E.D. Mich. 2015).
164. In re Dow Corning Corp., 541 B.R. at 649.
165. Id. at 650.
166. Id. at 650.
167. In re Dow Corning Corp., 541 B.R. at 650.
168. Id.
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Dr. Justus Fiechtner was the plaintiffs second expert.169 This
physician was a rheumatologist, and the Court decided this was
enough to establish his expertise in the field.170 However, the Court
found that Dr. Fiechtner's report lacked methodology, reasoning, and
analysis as to how the plaintiff was "predisposed" to autoimmune dis-
eases.171 Dr. Fiechtner admitted in a deposition that the probability of
silicone implants causing an autoimmune disease was less than fifty
percent, but, an expert attempting to establish proximate cause must
state his opinion to a more than a fifty percent likelihood.172 The Court
found Dr. Fiechtner's report would not assist the jury so his testimony
was also precluded.173
The plaintiffs third expert was Pierre Blais, Ph.D.17 4 Dr. Blais
was a specialist in the field relating to the chemical properties of sili-
cone gel, however, he could not agree that the silicone gel caused the
plaintiffs diseases since he was not a medical doctor.175 Even though
Dr. Blais' research would assist the jury in regards to the chemical
properties of silicone, his testimony was speculative as to whether the
silicone actually caused injuries.176 Additionally, other courts have
held that Dr. Blais' testimony was unreliable. Therefore, this Court ex-
cluded his testimony as to the cause of the plaintiffs injuries.177
Defendants then moved for summary judgment, claiming that
the plaintiff could no longer establish causation without any expert re-
ports.178 The plaintiff asserted that the defendants' renewed motion
demonstrated an attempt to discredit the opinions of the proposed ex-
perts, and because the plaintiff had already been awarded Social
Security benefits, the issue of causation had been determined.179 The
Court disagreed and ruled in favor of the defendants; holding that be-
cause all of plaintiffs expert testimony had been excluded, she had no
way to prove causation.180
In Norris v. Baxter Healthcare Corporation, the plaintiff re-
ceived silicone gel breast implants in 1974, manufactured by the
169. In re Dow Corning Corp., 541 B.R. at 651.
170. Id. at 651-52.
171. In re Dow Corning Corp., 541 B.R. at 651-52.
172. Id. at 652.
173. Id.
174. In re Dow Corning Corp., 541 B.R. at 652.
175. Id. at 653.
176. Id.
177. Id. at 653.
178. In re Dow Corning Corp., 541 B.R. at 654.
179. Id. 654-55.
180. Id. at 654-55.
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defendant's predecessor.18l In 1978, her right implant ruptured and
the plaintiff had both implants replaced with a set manufactured by
Dow Corning.182 The plaintiff sued Baxter, alleging the ruptured im-
plant in 1978 caused a series of ailments, including one doctor's belief
that she had silicone-induced lupus.8 3
In silicone breast implant litigation, plaintiffs must show both
general causation, meaning the substance can cause a particular in-
jury, and specific causation, meaning the substance caused a
particular individual's injury.184 The Court concluded that epidemio-
logical studies are the best evidence of general causation in a toxic tort
case.185
The plaintiff presented two experts, Dr. Vasey and Dr. Espi-
noza.186 The District Court excluded both experts, using Federal Rule
of Evidence 702 and the Daubert factors, because the experts were un-
reliable as they did not use epidemiological studies in their reports.18 7
The Court of Appeals agreed that both doctors' testimony should be
excluded.188 Even though the experts are qualified in the field of rheu-
matology, they ignored or discounted many of the epidemiological
studies finding no reliable link between silicone breast implants and
systemic disease.189 The methodology used by both doctors was deemed
not medically or scientifically valid.190 The doctors' reports relied solely
on differential diagnosis and case studies to establish a link between
silicone implants and systemic disease, however, this directly contra-
dicted all available epidemiological studies.191 The Court held that in
such cases of blatant disagreement, summary judgment for the defen-
dant is appropriate.192
181. Norris v. Baxter Healthcare Corp., 397 F.3d 878, 879 (10th Cir. 2005).
182. Id. at 880.
183. Id.
184. Norris, 397 F.3d at 881.
185. Id. at 882.
186. Id. at 883.
187. Id.
188. Norris, 397 F.3d at 886.
189. Id. at 885.
190. Id. at 884.





In Vernon v. Benson, the plaintiff sued Dr. Royal Benson for in-
juries resulting from a breast augmentation procedure.193 During this
operation, the plaintiff alleged Dr. Benson caused a pneumothorax,
which is commonly caused when a needle for local anesthesia is ad-
vanced too far or is misplaced and enters the pleural cavity.194
Dr. William Gorman, the plaintiffs expert, opined that Dr. Ben-
son breached the standard of care by causing Vernon to suffer a
pneumothorax.9 5 Dr. Gorman opined that the defendant strayed
outside of the normal dissection plane and entered the pleural cav-
ity.1 9 6 Combined with the fact that plaintiff showed no signs of a
pneumothorax before the procedure, Dr. Gorman concluded the pneu-
mothorax was the fault of the surgeon.197 In the recovery room, the
patient complained of shortness of breath and chest wall pain, but the
pneumothorax went undiagnosed for nearly a week.'9 8 Dr. Gorman
stated these symptoms should never be ignored, and that Dr. Benson
breached the standard of care for surgical treatment and postoperative
care.199
At trial, Dr. Benson filed a motion to dismiss based on Dr.
Gorman's failure to provide a fair summary of the standard of care as
well as what the defendant should have done differently to prevent and
treat the pneumothorax.200 The trial court, however, found Dr.
Gorman's reports discussed the appropriate standard of care with suf-
ficient specificity to fulfill the statutory requirements.2 0 1 The court of
appeals stated Dr. Gorman's reports need only to fulfill two purposes:
"(1) inform Dr. Benson of the specific conduct [plaintiffi called into
question; and (2) provide a basis for the trial court to conclude that the
claims have merit."202 The court of appeals upheld the trial court's de-
cision, noting that "[a]n expert report need not marshal all of the
plaintiffs evidence," as long as the required purposes are fulfilled. 203
193. Vernon v. Benson, 303 S.W.3d 755, 757 (Tex. App. 2009).
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In Flannery v. President and Director of Georgetown College, the
plaintiff filed suit after breast enlargement surgery allegedly resulted
in a hemopneumothorax, which is essentially blood and air in the
lungs.2 0 4 The plaintiff claimed this was caused as a result of a local
anesthetic procedure called an intercostal nerve block.205 The defen-
dant informed the plaintiff of the risks of the surgery itself, but she
was not warned about the dangers associated with the anesthetic
procedure.206
The record showed there was no warning about
hemopneumothorax; however, the plaintiff must also establish an ex-
isting causal relationship between the physician's failure to adequately
divulge the risk and the damage to the patient.2 0 7 The plaintiff testi-
fied that she would have forgone surgery had she known about the risk
of a hemopneumothorax, but not if she knew the risk of a pneumotho-
rax.2 0 8 She also did not prove that she would have selected general
anesthesia as opposed to a local anesthetic had she known the risk of a
pneumothorax.209 While the court agreed that a patient should be
warned of all material risks, it stated that the claimant failed to estab-
lish a causal link between a failure to warn and the injuries she
suffered.2 1 0 Therefore, a directed verdict in favor of defendant was
appropriate.2 11
H. Cancer
In In re Silicone Gel Breast Implants Products Liability Litiga-
tion, the plaintiff was the administrator of Toni Cagle's estate, who
was diagnosed with breast cancer about fourteen months after receiv-
ing breast implants.212 The plaintiff alleged the implants caused or
accelerated the cancer.2 1 3 The plaintiff did not allege that the silicone
itself caused or accelerated the cancer, but instead maintained that the
polyurethane foam ("PUF"), which coated the implants, broke down in




207. Flannery, 679 F.2d at 962.
208. Id.
209. Id.
210. Id. at 962-63.
211. Id. at 963.
212. In re Silicone Gel Breast Implants Prods. Liab. Litig., 318 F. Supp. 2d 879, 886
(C.D. Cal. 2004).
213. Id. at 886.
126
BREAST AUGMENTATION SURGERY
vivo into 2,4-toluene diamine ("TDA"), which he claimed was
carcinogenic.2 1 4
The defendants filed four motions in limine to exclude the testi-
mony of the plaintiffs four causation experts: (1) Dr. Neugebauer (an
epidemiologist), (2) Dr. Batich (a polymer chemist), (3) Dr. Lappe (a
toxicologist), and (4) Dr. Shanklin (a pathologist).215 The plaintiffs
causation theory, which relied heavily on expert reports, was as
follows:
One epidemiological study provided "suggestive evidence" of a
causal link between PUF-coated implants and cancer; the PUF
coating biodegrades after implantation in humans; the degradation
products of the PUF-coating include TDA; TDA is known to be car-
cinogenic in animals and is a "probable" human carcinogen; and the
amount of TDA likely to be released from Cagle's implants, Cagle's
pregnancy (which began almost immediately after implantation)
and the rare type of breast cancer Cagle suffered renders it more
likely than not that her tumor was caused by or its growth acceler-
ated by TDA released from her implants.
216
The court ruled that the plaintiff was unable to offer scientifically reli-
able evidence to support the last proposition, and therefore, even
assuming the first four theories were admissible, summary judgment
was appropriate because the plaintiff could not establish the breast im-
plants caused the decedent's cancer.2 1 7
In Enholm v. Cohen, the plaintiff employed Dr. Steven Cohen to
replace breast implants she had received in 1978.218 This procedure
also involved injecting fat cells in her chest wall to produce softer
breasts.2 19 Five months after the surgery, the plaintiff was diagnosed
with uterine cancer, which she attributed to the fat cell injections.2 2 0
She sued Dr. Cohen, alleging he failed to obtain her informed consent,
the physician committed fraud, and the fat cell injections violated FDA
regulations.221
The fat injection procedure, called cell-enhanced fat transfer
("CEFT"), involves removing fat by liposuction from one area of the pa-
214. In re Prods. Liab. Litig., 318 F. Supp. 2d at 887.
215. In re Prods. Liab. Litig., 318 F. Supp. 2d at 887.
216. Id. (alteration in original).
217. Id.
218. Enholm v. Cohen, No. D067252, 2016 WL 142297, at *1 (Cal. Ct. App. Jan. 12,
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tient's body and re-introducing it into the patient's breasts.2 2 2 The
patient asserted that Dr. Cohen did not inform her of the risks, and
that the procedure was not FDA-approved.2 2 3 Additionally, had she
known about the risks, the plaintiff maintained that she would not
have had the surgery.224
Defendant's expert stated Dr. Cohen's "pre-operative care, con-
sent discussions, and information provided to the patient on the CEFT
procedure and study were at all times within the appropriate standard
of care."2 2 5 The plaintiff admitted at her deposition that "(1) she had no
complaints about the surgical results, (2) no physician had attributed
her ovarian cancer to the surgery, and (3) she sustained no physical
injury from the surgery . . . ."2 2 6 Based upon this testimony, as well as
other evidence, the court granted summary judgment in favor of Dr.
Cohen.2 2 7
The Court of Appeals upheld the granting of summary judg-
ment.2 2 8 The Court noted the plaintiff submitted no expert testimony
to refute the defendant's expert, nor did she present any evidence of
actual damages.2 2 9 Even though the patient tried to present newly-dis-
covered evidence on appeal, the facts were still overwhelmingly in
favor of Dr. Cohen.2 3 0
I. Temporary Restraining Order
In Baker v. Patterson, the plaintiffs filed a Motion for Tempo-
rary Restraining Order asking the court to force Dr. Patterson to
disclose all information available to him regarding the source of the
breast implants he placed in plaintiffs' breasts.2 3 1 The claimants al-
leged that Dr. Patterson used non-FDA approved implants
manufactured in China when he performed their surgeries.2 3 2
In order to obtain a temporary restraining order ("TRO"), the
moving party must show: "(1) a likelihood of success on the merits; (2) a
222. Cohen, 2016 WL 142297, at *1.
223. Id.
224. Id. at *5.
225. Id. at *9.
226. Cohen, 2016 WL 142297, at *4.









likelihood of irreparable harm to the moving party in the absence of
preliminary relief; (3) that the balance of equities tips in favor of the
moving party; and (4) that an injunction is in the public interest."2 3 3
The District Court granted the TRO for only one plaintiff, Camille Ad-
ams, because her allegations indicated a likelihood of irreparable harm
for the potential physical and emotional damage from non-FDA ap-
proved implants and the potential removal of the breast implants.2 3 4
Additionally, the balance of equities tipped strongly in her favor in
light of the potential harm, and the absence of any cognizable hardship
to Dr. Patterson from disclosing the information.235 Further, public
policy was in favor of granting the TRO because it reflects the general
interest in the safety of medical devices.236
J. Medical Malpractice
Aills v. Boemi involves one of the more substantial verdicts in-
volving breast augmentation surgery.237 The defendant removed
several hundred grams of tissue from each breast and inserted saline
implants enlarged to their maximum capacity.238 These actions inter-
fered with the circulation of the blood causing necrosis to the
remaining breast tissue, skin, and nipples.239 This caused her to un-
dergo thirteen corrective surgeries.240 The plaintiff alleged negligence
and lack of informed consent in that the doctor failed to tell her that
a breast augmentation could result in harm to her body.241 A verdict of
$8,250,000 was rendered by the jury.2 4 2
In Froneberger v. Owens, the plaintiff appealed from the grant-
ing of defendant's motion for summary judgment.243 In 2008,
Froneberger was diagnosed with an aggressive form of breast cancer,
and underwent a mastectomy on her left breast.2 44 Dr. Owens was pre-
233. Baker, 2016 WL 3024017 (quoting Idaho v. Coeur d'Alene Tribe, 49 F. Supp. 3d
751, 762 (D. Idaho 2014)).
234. Id.
235. Baker, 2016 WL 3024017, at *2.
236. Id.
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sent in the operating room to create a "pocket" by placing an expander
under her skin to allow for the eventual placement of a gel-based im-
plant.2 4 5 Dr. Owens performed the implant surgery in August 2010,
and about two and a half weeks later, the plaintiff complained of pain
and swelling in her breast.246 After a visit to the hospital, it was de-
cided the implant needed to be removed so the pocket could be cleared
of infection, which Dr. Owens subsequently did.2 4 7 The patient sued
Dr. Owens alleging medical negligence.248
The plaintiff presented one expert, Dr. Kraus, whose deposition
surprisingly provided the basis for the granting of summary judgment
in favor of the defendant.249 Dr. Kraus initially testified that Dr.
Owens departed from the standard of care by not having a variety of
sizes and shapes of implants available when she performed the im-
plant surgery, and that the implant used was either too large or not
the proper shape, leading to the infection.250 However, later in the dep-
osition, Dr. Kraus stated the implant itself could not have caused the
infection to a reasonable degree of medical certainty.251 The trial court
granted the defendant's motion for summary judgment because the ex-
pert's testimony did not "[offer] any of the factual underpinnings in the
chain of causation."252 Finding no abuse of discretion on the part of the
trial court, the Court of Appeals upheld the ruling.253
In Ditto v. McCurdy, the plaintiff sued Dr. McCurdy, an ear,
nose, and throat specialist and cosmetic surgeon, alleging negligence
and fraud stemming from a breast augmentation procedure.254 The pa-
tient needed seven surgical procedures, some of which were performed
without anesthesia, until the implants were removed.255 The jury
awarded $3,500 in special damages, $1,000,000 in general damages,
$400,000 in damages for fraud, and $600,000 in punitive damages.256
245. Froneberger, 2016 WL 770003.
246. Id.
247. Owens, 2016 WL 770003, at *2.
248. Id.
249. Id. at *3.
250. Id.
251. Id. at *3-4.
252. Owens, 2016 WL 770003, at *6.
253. Id. at *11.
254. Ditto v. McCurdy, 947 P.2d 952, 954 (Haw. 1997) (hereinafter Ditto II).
255. Ditto v. McCurdy, 947 P.2d 961, 969-71 (Haw. Ct. App.), as amended (June 20,
1997), affd in part, rev'd in part, 947 P.2d 952 (1997).
256. Ditto II, 947 P.2d at 954.
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The Supreme Court of Hawaii reversed the finding of liability with re-
spect to the fraud count and vacated the award of punitive damages.257
The plaintiffs claim for fraud was premised on the fact that Mc-
Curdy had a duty to disclose that he was not a board certified plastic
surgeon; this fact was material to her decision to allow the defendant
to perform the surgery.258 Dr. McCurdy rebutted this allegation with
two experts, who claimed that there is confusion relating to two differ-
ent certifying boards, and that Dr. McCurdy is a member of one of
them.259 Additionally, the surgeon argued that, a physician does not
have an affirmative duty to disclose his qualifications to a patient prior
to providing treatment.260 The Court agreed and stated that the doc-
trine of informed consent merely means that a doctor has an
affirmative duty to disclose the types of risks and alternatives to a pro-
posed treatment or surgery.261 The Court reasoned that Dr. McCurdy
was certified as an otolaryngologist, facial surgeon, and cosmetic sur-
geon, and always held himself out to be so.2 6 2 Further, this is a matter
for the legislature and the board of medical examiners, and not the
courts.2 6 3 Accordingly, because Dr. McCurdy did not have an affirma-
tive duty to disclose his qualifications, he cannot be found liable for
fraud.264
K Emotional Distress
In Maurer v. Heyer-Schulte Corporation, the plaintiff claimed
that she developed a fear of cancer after breast augmentation surgery,
alleging, inter alia, deformation, scarring, several auto-immune dis-
eases, mental pain and suffering, and the physical injury of having a
carcinogen placed in her body.2 6 5 In order to prevail on a fear of cancer
claim, the plaintiffs fear must be reasonable and causally related to
the defendant's negligence.266 The plaintiff does not need to prove the
implants will lead to cancer, but must show that there is "any possibil-
257. Id.
258. Ditto II, 947 P.2d at 955.
259. Id. at 955-56.
260. Ditto II, 947 P.2d at 958.
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262. Ditto II, 947 P.2d at 958.
263. Id. at 958-59.
264. Id. at 959.
265. Maurer v. Heyer-Schulte Corp., No. CIV.A. 92-3485, 2002 WL 31819160, at *1
(E.D. La. Dec.13, 2002).
266. Id. at *3.
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ity of acquiring a disease, no matter how remote ." 2 6 7 However, the
patient has to produce at least some reliable scientific evidence that
breast implants can cause cancer.2 68
The surgeon produced two scientific reports which found that
there is no association between breast implants and cancer, as well as
voluminous epidemiological studies showing no causal link between
breast implants and cancer.269 The Court concluded, based on the large
amount of evidence produced by the surgeon, that the defendant had
met his burden in showing that the plaintiffs fear of developing cancer
was unreasonable as a matter of law.2 7 0 The patient merely submitted
a handwritten memorandum and a committee staff report in support of
her position, neither of which can be considered conclusive scientific
evidence.2 7 1
CONCLUSION
Breast augmentation is one of the most popular forms of plastic
surgery. This growth is a reflection of the number of physicians per-
forming the techniques, reduced costs, and the less-invasive nature of
the modifications. After all, the procedure offers instant gratification
but it is not without risk. Complications range from an infection to per-
manent nerve damage and even death.
Breast augmentation uses different substances, such as saline
or fat to enlarge breast size, to reestablish breast dimension or to re-
construct the chest area after a mastectomy or injury. Common
difficulties associated with implants are capsular contracture, addi-
tional surgery, implant removal, rupture or deflation of the implant,
and bleeding. Occasionally, patients are not pleased with the aesthet-
ics of the implants, claiming that they are malpositioned,
asymmetrical, too large or too small, fake in appearance, or their scars
are too wide or thick.
Breast implant litigation enjoys a robust, but controversial his-
tory. The first successful lawsuit over ruptured breast implants
occurred in 1977 and million dollar verdicts became common place. The
media's coverage over silicone breast implants exploded in 1991 as the
result of a $25 million verdict against a manufacturer. This verdict was
roundly criticized in the American Medical Association's Journal of
267. Id.
268. Maurer, 2002 WL 31819160.
269. Id. at *1.
270. Id. at *4.
271. Maurer, 2002 WL 31819160, at *4.
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Ethics and it was claimed that the plaintiffs lawyer generated a great
deal of sympathy for his client by hiring a public relations firm that
obtained interviews with a variety of television shows. Contemporane-
ously, the FDA ordered manufacturers of silicone gel breast implants
to provide additional studies. They noted that the existing research
was insufficient to prove the safety of the devices.
These developments caused several manufacturers to withdraw
from the breast implant business. Likewise, more women with breast
implants have stepped forward asserting a multitude of issues, and a
small group of experts continue to link breast implants to the develop-
ment of autoimmune disease without any real scientific basis to
support their conclusions.
The wheels come off the wagon in the plaintiffs' successful run
of breast implant litigation in 1994 as the result of a study conducted
by the Mayo Clinic. The 30-year study published in the New England
Journal of Medicine found no connection between breast implants, con-
nective-tissue diseases and other disorders. This was followed by
pronouncements from a variety of other groups who also found no con-
nections between breast implants and disease. Even the FDA ended up
reversing its position.
From a litigation point of view, the dockets contain thousands of
lawsuits involving breast implants. The volume of cases, however, is
much less than it was 40 years ago, during the frenzy over the safety of
the devices. Nevertheless, breast augmentation is still a surgical proce-
dure with its attendant complications and unfulfilled expectations by
some patients. The types of lawsuits and theories of liability run the
gamut like any other surgical procedure, but at least they no longer
attempt to link the implants to a variety of diseases based upon flawed
scientific studies.
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